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SUMMARY
Salmonellosis is an internationally important disease of mammals and birds. Unique epidemics in
New Zealand in the recent past include two Salmonella serovars : Salmonella enterica subsp.
enterica serovar Typhimurium deﬁnitive type (DT) 160 (S. Typhimurium DT160) and
S. Brandenburg. Although not a major threat internationally, in New Zealand S. Typhimurium
DT160 has been the most common serovar isolated from humans, and continues to cause
signiﬁcant losses in wildlife. We have identiﬁed DNA diﬀerences between the ﬁrst New Zealand
isolate of S. Typhimurium DT160 and the genome-sequenced strain, S. Typhimurium LT2.
All the diﬀerences could be accounted for in one cryptic phage ST64B, and one novel P22-like
phage, ST160. The majority of the ST160 genome is almost identical to phage SE1 but has two
regions not found in SE1 which are identical to the P22-like phage ST64T, suggesting that ST160
evolved from SE1 via two recombination events with ST64T. All of the New Zealand isolates of
DT160 were identical indicating the clonal spread of this particular Salmonella. Some overseas
isolates of S. Typhimurium DT160 diﬀered from the New Zealand strain and contained SE1
phage rather than ST160. ST160 was also identiﬁed in New Zealand isolates of S. Typhimurium
DT74 and S. Typhimurium RDNC-April06 and in S. Typhimurium DT160 isolates from the
USA. The emergence of S. Typhimurium DT160 as a signiﬁcant pathogen in New Zealand is
postulated to have occurred due to the sensitivity of the Salmonella strains to the ST160 phage
when S. Typhimurium DT160 ﬁrst arrived.
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INTRODUCTION
Non-typhoidal salmonellosis ranks second among the
most frequently reported gastrointestinal diseases in
humans in New Zealand, and third among diseases
worldwide [1]. In New Zealand, two Salmonella sero-
vars have emerged as major epidemic strains in the re-
cent past, Salmonella enterica subsp. enterica, serovar
Typhimurium (deﬁnitive type or phage type) DT160
(S. Typhimurium DT160) and S. Brandenburg [2–4].
This contrasts with the serovars causing global
pandemics, S. Enteritidis PT4 and S. Typhimurium
DT104 [5, 6] neither of which are signiﬁcant causes
of infection in New Zealand. Surveillance reports
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published by the Institute of Environmental Science
and Research Limited (ESR) show that since 1997
the reported incidence of salmonellosis caused by
S. Typhimurium DT160 throughout New Zealand
has increased with a major epidemic occurring around
2001 [7, 8]. Although reported incidences have de-
creased somewhat since then, S. TyphimuriumDT160
remains the single most common cause of salmon-
ellosis in humans in New Zealand [3, 8, 9].
The host range of S. Typhimurium DT160 in-
cludes humans, farmed animals and wild birds [3, 10].
Although the strain is not a major cause of sal-
monellosis internationally it frequently causes gastro-
intestinal disease in humans and other mammals
in New Zealand, and widespread mortality in birds
due to septicaemia [2, 9]. It is possible that the
New Zealand isolates of S. TyphimuriumDT160 have
acquired gene(s), probably by horizontal gene trans-
fer, that have enabled them to emerge as epidemic
pathogenic strains in this geographically isolated
country. The aim of this study was to identify candi-
date genes that may have enabled S. Typhimurium
DT160 to become established and persist in human
and animal populations in New Zealand.
METHODS
Bacterial strains and culture conditions
The Salmonella strains used in this study are listed in
Table 1. Salmonella strains were incubated aerobically
at 37 xC on Tryptic Soy (for subtractive hybridization
and DNA puriﬁcation) or Luria–Bertani (LB) broth
or agar plates (for phage work). All Escherichia coli
strains which hosted the subtractive genomic DNA
library were grown in LB medium supplemented with
50 mg/ml ampicillin or 50 mg/ml kanamycin, under
similar conditions to those used for the Salmonella
cultures.
Puriﬁcation of phage
Phages were puriﬁed from the spent media of un-
induced stationary phase cultures or from induced
cultures 2 h or 16 h after adding mitomycin C (ﬁnal
concentration 2 mg/ml) at mid log phase [11], using
phage-deﬁcient host strain, TT23564 (Table 1). Phage
plaques were transferred from agar into the tips of
Pasteur pipettes, suspended in 10 mM Tris (pH 7.4),
15 mM NaCl, 10 mM MgSO4 and 3.4% chloroform,
and stored at 4 xC. For preparation of high-titre phage
stocks, phages were propagated by mixing approxi-
mately 1013 p.f.u. in 0.7r LB broth, 0.5r no citrate E
media [12], 1 mM MgSO4, 10 mM glucose with one-
fourteenth volume of TT23564 overnight LB liquid
culture and incubating overnight with shaking at
37 xC. Cell debris was removed by centrifugation and
ﬁltration, and stock solutions stored in 5% chloro-
form at 4 xC. Titres for these stocks ranged from 0.5 to
2r1015 p.f.u./ml.
Generalized transduction assays
To determine whether the S. Typhimurium DT160
phage was capable of transferring Salmonella DNA
between Salmonella hosts, phage propagated on the
chloramphenicol-resistant strain TT23564 was used
to test for the transfer of drug resistance to the
chloramphenicol-sensitive strain, LT2. For this assay,
100 ml of high-titre phage stock (1015 p.f.u./ml) was
mixed with 100 ml of an overnight LB culture of LT2,
and the mixture spread onto LB agar medium and
grown overnight at 37 xC. The resulting cell lawns
were then replica-plated onto LB agar medium con-
taining chloramphenicol at a ﬁnal concentration of
10 mg/ml and grown overnight at 37 xC.
Transmission electron microscopy (TEM)
High-titre phage stock was diluted 50-fold into 1 mg/
ml BSA and deposited onto Formvar/carbon grids,
negatively stained in 2% potassium phosphotung-
stinate (pH 7.0) and examined on a Philips CM10
transmission electron microscope.
DNA puriﬁcation
Genomic DNA for suppression subtractive hybrid-
ization (SSH) and Southern blotting experiments
Table 1. Strains for subtractive hybridization and phage isolation
Strain Salmonella serovar/subtype Year isolated Source/country
NZRM4363 S. Typhimurium LT2 1948 ATCC700720/USA
NZRM4347 S. Typhimurium DT160 1998 Human/NZ
TT23564 S. Typhimurium LT2 fels-2– Gifsy2– Gifsy1– camR 2002 Roth Lab/USA
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was prepared using the CTAB/NaCl method [13]. For
the gene survey experiments, a High Pure PCR tem-
plate preparation kit (Roche, New Zealand) was used.
Phage DNA was prepared from the ﬁltered spent
media of high-titre solutions. Phages were pelleted by
centrifugation, re-suspended in one-tenth volume of
TMK [20 mM Tris (pH 8.0), 2 mMMgCl2, 50 mM KCl]
and incubated overnight at 4 xC with 1.6 mg/ml
DNase1 and 0.5 mg/ml RNase A to remove residual
bacterial nucleic acids. DNA was puriﬁed following
SDS/proteinase K treatment, phenol extraction and
isopropanol precipitation.
Subtractive DNA hybridization
A SSH library was constructed using a PCR-Select
bacterial genome subtraction kit (Clontech, USA)
according to the manufacturer’s recommendations.
DNA from the ﬁrst isolated human S. Typhimurium
DT160 strain (NZRM4347) was used as the tester and
DNA from the genome-sequenced strain S. Typhi-
murium LT2 (ATCC 700720) was used as the driver.
Tester-speciﬁc DNA fragments were ampliﬁed using a
primary suppressive PCR; enriched using a secondary
PCR and cloned into pCR4 TOPO (Invitrogen, New
Zealand) cloning vector. The library was propagated
in TOP 10 chemically competent cells (Invitrogen).
The cloned DNA fragments were sequenced and the
data analysed using DNAMAN version 4.02 (Lynnon
BioSoft, Canada). BlastN and BlastX (www.ncbi.
nlm.nih.gov/blast) programs were used to search for
similar sequences [14].
Phage genome sequencing and annotation
Puriﬁed phage DNA was sequenced at the Depart-
ment of Anatomy and Structural Biology, University
of Otago, on a Genome Sequencer 20 454 GS FLX
sequencing instrument. Open reading frames (ORFs)
were identiﬁed using three diﬀerent analysis programs:
WebGeneMark.hmm [15], NCBI Open Reading
Frame Finder (ORF Finder) from the National Cen-
tre for Biotechnology Information website (http://
www.ncbi.nlm.nih.gov/gorf/gorf.html) and Genamics
Expression v. 1.00 software (Genamics,NewZealand).
All putative ORFs of o100 bp were scanned against
the GenBank databases using the BLAST suite of
programs. The Genbank results for each ST160 ORF
against SE1, ST104, P22 and ST64T, if applicable, are
provided in Supplementary Table 1 (available online).
Sequencing of phage PCR products from a range of
Salmonella strains was performed by conventional
sequencing.
orf23 PCR assay
Salmonella serovars were screened for the presence of
ST160 using a PCR assay that targeted orf23, which
was only found in ST160 and SE1. PCR ampliﬁcation
was performed using AmpliTaq Gold1 PCR Master
Mix (Applied Biosystems) and the primers orf23-for
(5k-GTCTTTCGAACTGCTGGA) and orf23-rev (5k-
AACCAATGCCGAAGTCA). The ampliﬁcation re-
actions (25 ml) contained 1 ml puriﬁed DNA, and
0.2 mM of each primer. Ampliﬁcation conditions were
as follows: an initial denaturing step of 94 xC for
5 min, followed by 35 cycles of 95 xC for 15 s, 55 xC
for 15 s, then 72 xC for 30 s, with a ﬁnal elongation
step of 72 xC for 7 min. Following ampliﬁcation, 5 ml
of the ampliﬁcation product was analysed by agarose
gel electrophoresis.
Southern blot analysis
Puriﬁed DNA from a variety of Salmonella strains
was digested with NcoI (NEB, New Zealand), electro-
phoresed through a 1% agarose gel and transferred to
a Zeta probe nylon ﬁlter (Bio-Rad, New Zealand) for
Southern blotting. Filters were hybridized with a
puriﬁed orf23 PCR product labelled with [32P]dCTP
by nick translation.
Identiﬁcation of SE1 and ST160 within
S. Typhimurium isolates
Two regions that diﬀered signiﬁcantly between ST160
and SE1 (Fig. 1) were ampliﬁed and characterized
using primers, Reg1F (5k-GTTGCTGCATAATC-
GCTGAA) and Reg1R (5k-TTCCGTTCGTATC-
ACGTCAG) for Region 1, and Reg2F
(5k-AAGAAACGACGACGAGAGGA) and Reg2R
(5k-GAGCTAATGCCGTTCCTTCA) for Region 2.
The ampliﬁcation reactions (50 ml) contained 1 ml
puriﬁed DNA, and 0.2 mM of each primer. The am-
pliﬁcation conditions were as follows: an initial de-
naturing step of 94 xC for 2 min, followed by 35 cycles
of 95 xC for 30 s, 59 xC for 30 s, then 72 xC for 4 min,
with a ﬁnal elongation step of 72 xC for 10 min. Fol-
lowing ampliﬁcation, 20 ml of product was digested
with RsaI and the fragments separated on a 2%
agarose gel. The restriction patterns identiﬁed either
ST160 or SE1 and were conﬁrmed by sequencing.
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Survey of S. Typhimurium and S. Enteritidis for
susceptibility to ST160
The serotypes of 640 suspected S. Typhimurium and
S. Enteritidis isolates were identiﬁed according to the
Kaufmann–White Scheme and then phage-typed
[16, 17]. A stock solution of>104 p.f.u./ml propagated
phage ST160 was diluted and used alongside the ref-
erence phage panel during routine laboratory phage-
typing of S. Typhimurium and S. Enteritidis isolates.
RESULTS
Identifying diﬀerences between S. Typhimurium
DT160 and LT2
Within the 432 cloned fragments from the SSH library
41 contained sequences not present in LT2. The 41
clones contained 26 unique sequences and the ma-
jority of these (14/26) were homologous (o99%) to
sequences from the genome of P22 and the P22-like
phages ST64T and ST104 [18]. These sequences and
sequence from three other clones were subsequently
found within the ST160 phage genome. The remain-
ing sequences (9/26) were closely related to the P27
group member, ST64B [18]. The results of the SSH
experiment were conﬁrmed by PCR using speciﬁc
primers designed from the sequences of the clones
(results not shown).
Isolation of phage from S. Typhimurium DT160
Propagation of the spent media from NZRM4347 on
TT23564 gave three diﬀerent plaque morphotypes
that had a similar appearance but varied in size. Upon
re-propagation, each morphotype gave the same mix-
ture of diﬀerent-sized plaques, and DNA from each
morphotype gave the same restriction patterns when
cut with EcoRI, BamHI, BglII, SalI and NcoI (data
not shown). This novel phage isolate is hereafter re-
ferred to as ST160. Most S. Typhimurium DT160
isolates shed similar amounts of phages. Several no-
table exceptions included the Colindale S. Typhi-
murium DT160 type strain used as part of the
S. Typhimurium phage-typing scheme, and two
S. Typhimurium DT160 bird isolates from the USA
and Denmark for which there were no observed
plaques from the spent media of stationary phase
cultures either with or without added mitomycin C.
Further analysis of the Colindale S. Typhimurium
DT160 type strain revealed sporadic release of de-
tectable phage into log phase cultures, but no detect-
able phage from the same cultures when they reached
stationary phase, suggesting a much lower level of
spontaneous induction or perhaps less stable phage.
Characterization of ST160 via TEM and generalized
transduction assay
TEM revealed that this phage has an icosahedral-
shaped head and very short tail (Fig. 2), making it a
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Fig. 1. Dot plot comparing genome sequence of ST160 with
SE1 and ST64T generated using the NCBI BLAST search
comparing two sequences and the dot plot generated as part
of the output.
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Fig. 2. Transmission electron micrograph of ST160 virions.
Virions were prepared, negatively stained and examined as
described in the Methods section.
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member of the Podoviridae family [18]. A generalized
transduction assay recovered between 200 and 500
chloramphenicol-resistant colonies from 1014 p.f.u.,
showing that ST160 was able to eﬃciently transfer a
drug resistance marker between Salmonella strains.
ST160 genome sequencing
The 40986-bp genome of ST160 (Genbank accession
number GU573886) had 64 identiﬁable ORFs (Sup-
plementary Table 1, online). Genome analysis clearly
shows that ST160 is most closely related to the P22-
like phages (e34, ES18, P22, ST104, ST64T) including
the recently deposited sequence of phage SE1 (ac-
cession number NC_011802). The overall GC content
of phage ST160 was 47.1% which is similar to the
phages ST64T (47.5%), SE1 (47.0%), P22 (47.1%)
and ST104 (47.3%). ST160 is most closely related to
ST64T and SE1, sharing 37 ORFs with SE1 and 36
ORFs with ST64T (o99% identity at the amino-acid
level). ST160 also shares nine ORFs with P22, and 20
ORFs with ST104 (o99% identity at the amino-acid
level).
The ST160 genome, like many other phages, has a
mosaic structure. It contains eight ORFs which are
identical to ORFs in the ST64T genome (orf66, kil,
gp17, orf232, gp23, gp13, gp19, gp15) but have no
homology to ORFs in the SE1 genome, and 12 ORFs
that are identical to ORFs in SE1 (orf7, orf8, orf9,
orf10, orf23, orf24, c2, cro, orf28, ninG, ninY, orf64)
but little homology to ORFs in ST64T and some re-
gions that are present in both of these phage genomes
as well as in those of other P22-like phages. No unique
ST160 ORFs were identiﬁed (Fig. 1).
orf23 assay
An orf23PCR showed that allS. TyphimuriumDT160
isolates were positive for orf23 as were S. Typhi-
murium DT74 (seven isolates) and S. Typhimurium
RDNC-April-06 (ﬁve isolates). All other isolates tested
were negative (Table 2). Detection of the orf23 target
Table 2. Screening of isolates for the orf23 locus, ST160 or SE1 phage and shedding of ST160 phage
Serotype and strain or
phage type
No. of isolates
characterized Source
orf23 PCR
result*
ST160
or SE#
Southern blot
band size (kb)
Shed
ST160$
Typhimurium LT2 1 ATCC x n.d. No band n.d.
Typhimurium DT160 1 Colindale, UK + SE1 7.3 x
Typhimurium DT74 1 Colindale, UK + SE1 n.d. n.d.
Typhimurium DT160 9 NZ + ST160 12.3 +
Typhimurium DT160 2 USA + ST160 12.3 +
Typhimurium DT160 1 NZ + ST160 12.3 x
Typhimurium DT160 1 USA + SE1 7.3 x
Typhimurium DT160 1 Denmark + SE1 7.3 x
Typhimurium DT160 8 USA + ST160 n.d. n.d.
Typhimurium DT74 1 NZ + ST160 12.3 +
Typhimurium RDNC-April06 1 NZ + ST160 n.d. n.d.
Typhimurium RDNC-May06 1 NZ x n.d. No band n.d.
Typhimurium DT101 1 NZ x n.d. No band n.d.
Typhimurium DT12a 1 NZ x n.d. No band n.d.
Various serotypes· 19 NZ x n.d. No band n.d.
Bacteriophage P22 1 TR6771 x n.d. n.d. n.d.
Bacteriophage ST104 1 NZRM3970" x n.d. n.d. n.d.
Bacteriophage ST160 1 NZRM4347 + n.d. n.d. n.d.
n.d., Not done.
* +, PCR product observed; –, no visible PCR product.
# The presence of ST160 or SE1 was determined by PCR of Region 1 and 2 and digestion of the products (see Material and
Methods).
$ +, ST160 phage detected in spent media from an un-induced stationary phase culture ; –, no ST160 phage detected in spent
media from an un-induced stationary phase culture.
· Serotypes tested were Brandenburg, Saint Paul, Infantis, Mbandaka, Wangata, Javiana, Kiambu, Livingstone, Derby,
Oranienburg, Rissen, Menston, Mississippi, Oslo, Virchow, Newport, Mana, Thompson, and Montevideo.
" NZRM, New Zealand Reference Culture Collection, ESR, Porirua, New Zealand.
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in non-S. Typhimurium DT160 isolates indicates
these strains may harbour ST160, SE1 or another
closely related but as yet uncharacterized phage.
Screen for the presence of orf23 via Southern blot
All S. Typhimurium DT160 isolates and a New
Zealand S. Typhimurium DT74 isolate hybridized to
an orf23-speciﬁc probe (Table 2). Two sizes of hybri-
dizing fragment were observed, a 12.3-kb or a 7.3-kb
fragment (Fig. 3). The New Zealand S. Typhimurium
DT160 and DT74 isolates, and one US S. Typhi-
murium DT160 isolate gave the 12.3-kb hybridizing
fragment in agreement with the ST160 genome se-
quence. The remaining overseas isolates tested, in-
cluding a S. Typhimurium DT74 isolate from the UK,
gave the 7.3-kb hybridizing fragment. All isolates with
the 7.3-kb orf23-hybridizing fragment had SE1-
related sequences in the two regions of diﬀerence
(Fig. 1) rather than ST160. These included the over-
seas isolates of S. Typhimurium DT160 from the
USA and Denmark, the Colindale S. Typhimurium
DT160 type strain and the Colindale S. Typhimurium
DT74 type strain used in the S. Typhimurium phage-
typing system. DNA puriﬁed from phage released by
the Colindale S. Typhimurium DT160 type strain had
the NcoI restriction pattern expected for SE1.
Survey of S. Typhimurium and S. Enteritidis for
susceptibility to ST160
Susceptibility to ST160 was tested using 639 human
and non-human isolates of S. Typhimurium and one
S. Enteritidis (Table 3). Approximately 67% (431/
640) of strains tested were susceptible to ST160 in-
cluding S. Typhimurium PT135 which at one time
represented the most common phage type in New
Zealand [19].
DISCUSSION
The ﬁrst human case of S. Typhimurium DT160 in
New Zealand was reported in 1998. Numbers of
NZ
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DT160
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Fig. 3. Southern hybridization of the orf23 region. A probe
based on the orf23 gene from the ST160 genome sequence
was used to screen Salmonella strains by Southern blot. The
Southern blot of NcoI-digested DNA puriﬁed from cultures
from three well isolated colonies of each indicated strain.
kb, Molecular size marker adjacent numbers indicate the
fragment size in kilobases. All strains analysed had either no
observable band (LT2 and most Salmonella serovars), the
predicted 12.3-kb band (all New Zealand and some overseas
S. Typhimurium DT160 isolates), or a 7.3-kb band
(Colindale and some overseas isolates) (see Table 2).
Table 3. S. Typhimurium susceptibility to ST160
Phage
type*
Number
sampled Susceptibility
40 3 +++
64 1 +++
89 1 +++
135 21 +++
66 1 ++
153 1 ++
154 8 ++
42 91 ++
1 133 +
9 31 +
126 4 +
155 7 +
PT1 6 +
41 15 +
156 79 +
8 28 +
78 1 ¡
104 1 x
29 2 x
23 5 x
22 1 x
12a 23 x
6 2 x
101 145 x
74 29 x
160# 1 x
+++, Conﬂuent lysis ; ++, semi-conﬂuent lysis ;
+, opaque lysis ;x no lysis.
* All are S. Typhimurium except PT1 which is S. Enteritidis
PT1.
# Colindale S. Typhimurium DT160 type strain.
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human cases rose steadily reaching a peak of 791 cases
in 2001. The rapid increase in isolation rates of
S. Typhimurium DT160 in the late 1990s and its
continuing presence in both human and non-human
isolates in New Zealand prompted our investigation
into the potential factors facilitating the rapid spread
of S. Typhimurium DT160. As a ﬁrst step SSH was
performed and this identiﬁed 26 DT160 speciﬁc frag-
ments, all of which encoded genes that were homolo-
gous to genes from a variety of prophages. Thirteen
of the SSH fragments identiﬁed were identical
to those found by another group using LT2 and a
New Zealand strain of DT160 following the same
procedure [20]. To further characterize these diﬀer-
ences, we isolated and sequenced ST160, a novel P22-
like phage, from S. Typhimurium DT160 cultures.
Evaluation of the SSH data in light of the newly dis-
covered ST160 genome sequence suggested that
DT160 harboured two prophages that were not pres-
ent in the genome of LT2, ST160 and ST64B.
Bacteriophage ST64B was initially isolated and
characterized simultaneously with ST64T from
S. Typhimurium DT64 [21]. ST64B and ST64T have
a similar outward appearance and their genomes
have a similar overall architecture, but individual
gene sequences share no signiﬁcant identity. In the
nomenclature described by Kropinski and colleagues
[18], ST64B is the single representative of the P27
group of Salmonella phages, since it most closely re-
sembles the shigatoxin-carrying phage P27, as well as
the serotype converting S. ﬂexneri phage V with re-
spect to its DNA packaging, capsid and tail genes. It
is more closely related to phages Mu and Fels2 than it
is to P22-like phages [8]. Despite numerous attempts
on a variety of diﬀerent Salmonella strains, ST64B has
yet to be propagated. The tail and tail-sheath genes
of ST64B are disrupted by fragments of genes from
other organisms and TEM analysis showed that it
fails to produce full-length tails [22]. The cryptic ver-
sion of ST64B in S. Typhimurium ATCC14028s and
SL1344 can be resuscitated to a viable form via a
frame-shift mutation in the tail gene region [23]. Even
though it is unable to lyse bacteria with a functional
immC region, ST64B can inﬂuence the phage type
of bacteria that harbour it [24]. Regions that are hom-
ologous to ST64B genome have been identiﬁed in
numerous S. Typhimurium phage types [24] as well as
in other Salmonella serotypes.
The ST160 phage genome, sequenced as part of
this study, is a mosaic composed of genes that most
closely resemble or are identical to genes in the
P22-like phage ST64T [25] or the SE1 phage. ST64T
is a P22-like phage that was puriﬁed and charac-
terized from a Salmonella strain commonly isolated
in Australia, S. Typhimurium DT64 [21], but rarely
found in New Zealand. ST64T is capable of infecting
a variety of diﬀerent Salmonella serovars. It can me-
diate phage-type conversion in lysogenized strains
and can undergo generalized transduction, packaging
and transfer of Salmonella DNA between host strains
[21]. Bacteriophage SE1 was originally puriﬁed from
an S. Enteritidis strain isolated from a hospitalized
patient in Spain [26]. It can infect numerous
Salmonella hosts inﬂuencing the properties of its bac-
terial host by facilitating lysogenic conversion, and
also undergoes generalized transduction [26]. Like
both ST64T and SE1 and other P22-like family
members, ST160 was also found to be capable of ef-
ﬁcient generalized transduction and is thus a potential
vehicle for horizontal gene transfer. It can also infect
a range of Salmonella hosts. ST160 shares 100%
identity with P22 in the region encoding the P22 attP
site, which includes the 46 identical base pairs of
the attB site within the thrW tRNA gene [27–29] in
Salmonella and other bacterial genomes. Thus ST160
integration is presumably via site-speciﬁc recombi-
nation within this thrW tRNA gene catalysed by
bacterial integration host factor and phage-encoded
integrase as demonstrated for P22 [28]. Approxi-
mately 36 kb of the 40-kb ST160 genome are 98%
identical to SE1 and the two regions in ST160 where
SE1 and ST160 diﬀer signiﬁcantly are 100% identical
to ST64T [apart from a diﬀerence in the number of
15-bp repeats in orf232 in Region 1 and a 1-bp de-
letion in the 400-bp region between gp23 (anti-
termination protein) and gp13 (holin) of ST160 in
Region 2] suggesting that the evolution of ST160 in-
volved recombination between SE1 and ST64T.
Detection of ST160 in isolates was hampered by the
lack of a ST160-speciﬁc target. The orf23 gene while
originally thought to be speciﬁc for ST160 was also
found in the recently released sequence of SE1. Using
the gene as a marker for ST160, a survey of isolates
showed that all S. Typhimurium DT160 isolates con-
tained the gene. The gene was also present in other
phage types, S. Typhimurium DT74 and S. Typhi-
murium RDNC-April06. This survey also revealed
that the S. Typhimurium DT160 isolates were divided
into those containing ST160 and those containing
SE1. All New Zealand S. Typhimurium DT160,
DT74 and RDNC-April06 isolates tested contained
the ST160 phage. In addition, a number of recent
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isolates from the USA (Table 2) also contained ST160
as judged by the orf23 PCR and Regions 1 and 2
diﬀerentiating PCR. All SE1-containing isolates ori-
ginated from outside New Zealand and included the
S. Typhimurium DT160 and DT74 type strains from
Colindale used as part of the S. Typhimurium phage-
typing scheme and two S. Typhimurium DT160 iso-
lates from birds, one from the USA and one from
Denmark. Stationary phase cultures of all but one
New Zealand DT160 isolates contained detectable
ST160 phages. One S. Typhimurium DT160 isolate
from New Zealand harboured ST160 as judged by
Southern blot analysis but failed to shed detectable
phage into stationary phase culture medium (Table 2).
It was not possible to detect viable phage in stationary
phase cultures of S. Typhimurium DT160 isolates
harbouring SE1.
All New Zealand strains of S. TyphimuriumDT160
are indistinguishable by PFGE suggesting clonal
spread of the organism in animal and human popu-
lations [2]. Diﬀerences were identiﬁed in the macro-
restriction proﬁles of New Zealand S. Typhimurium
DT160 and those from abroad but they were deemed
to be related. It is not apparent why S. Typhimurium
DT160 should be so proliﬁc inNewZealand yet remain
relatively innocuous elsewhere. Many S. Typhi-
murium phage types and at least one S. Enteritidis
phage type were lysed by ST160 but a number of
S. Typhimurium strains were resistant, suggesting
these strains may harbour prophage(s) which conveys
resistance to ST160 (Table 3). The immC region of
ST160 is identical to that of ST104 and ST64T which
explains the resistance of S. Typhimurium DT104 to
ST160.
Bacteriophage ST160 was shown to be consti-
tutively shed in culture and this shedding may provide
S. TyphimuriumDT160 with a competitive advantage
over susceptible S. Typhimurium phage types. One
possibility is that some of the strains of Salmonella
circulating in New Zealand at the time the ST160-
containing isolate was introduced were sensitive to the
phage and this enabled S. Typhimurium DT160 to
expand rapidly. The role of phage in promoting re-
sistant strains under competitive colonization con-
ditions has been demonstrated in Salmonella [30] and
Campylobacter [31]. A survey of strains that are sen-
sitive and resistant to ST160 (Table 3) shows that
around the time S. Typhimurium DT160 was intro-
duced the major types circulating in New Zealand
among humans and animals were S. Typhimurium
DT135, DT101 and DT1. S. Typhimurium DT101 is
resistant to the ST160 phage, but S. Typhimurium
DT1 and DT135 are sensitive. The number of human
infections caused by S. TyphimuriumDT135 andDT1
fell after 2000 whereas the number of S. Typhimurium
DT101 infections remained constant (Fig. 4). While
this is anecdotal evidence it is interesting to note that
the major causes of salmonellosis elsewhere in the
world are resistant to ST160.
Both S. TyphimuriumDT74 and RDNC-April2006
are rare phage types with very few reports of infec-
tions or outbreaks; no cases of S. Typhimurium
DT74 have yet been identiﬁed in Australia (G. Hogg,
personal communication). The observation that the
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Fig. 4. Isolation of S. Typhimurium DT160, DT135 and DT101 from patients in New Zealand from 1998 to 2008.
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New Zealand isolates of S. Typhimurium DT160
and DT74 contained ST160 whereas the Colindale
S. Typhimurium DT160 and DT74 type strains con-
tained SE1-like sequences suggests that the two phage
types are closely related. Given that, in New Zealand,
S. TyphimuriumDT74 emerged afterS. Typhimurium
DT160 it is possible that S. Typhimurium DT74 may
evolve from S. Typhimurium DT160 via a loss or gain
of a phage(s) giving rise to the small diﬀerence in
the phage-typing pattern. A change in deﬁnitive
phage type due to acquisition of particular phages
has been described previously [21]. The emergence
of other phage types such as RDNC-April06 con-
taining ST160 reﬂects the spread and uptake of the
phage within the New Zealand S. Typhimurium
population. The emergence and decline of epidemic
strains of Salmonella has been described [32] and is
due to a number of factors including acquisition of
virulence factors [33] but susceptibility to new phages
may well be critical to changes in S. Typhimurium
populations.
The evidence presented in this study shows that
there is more than one distinguishable type of S.
Typhimurium DT160. The evolution of this deﬁnitive
type has had a signiﬁcant impact on both human and
animal health in New Zealand. To understand the
risks posed by newly emerging strains of Salmonella
requires not only knowledge of their genetic make-up
but also knowledge of the Salmonella population into
which the new strain emerges.
NOTE
Supplementary material accompanies this paper on
the Journal’s website (http://journals.cambridge.org/
hyg).
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